chr16-21965441-G-A
Variant summary
Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM5BP4_StrongBP6_Very_StrongBA1
The NM_003366.4(UQCRC2):c.548G>A(p.Arg183Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0469 in 1,613,620 control chromosomes in the GnomAD database, including 2,191 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R183W) has been classified as Pathogenic.
Frequency
Consequence
NM_003366.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UQCRC2 | NM_003366.4 | c.548G>A | p.Arg183Gln | missense_variant | 7/14 | ENST00000268379.9 | NP_003357.2 | |
PDZD9 | XM_017023109.2 | c.607-7824C>T | intron_variant | XP_016878598.1 | ||||
PDZD9 | XM_047433888.1 | c.601-7824C>T | intron_variant | XP_047289844.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UQCRC2 | ENST00000268379.9 | c.548G>A | p.Arg183Gln | missense_variant | 7/14 | 1 | NM_003366.4 | ENSP00000268379 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0369 AC: 5605AN: 152076Hom.: 157 Cov.: 32
GnomAD3 exomes AF: 0.0393 AC: 9863AN: 250954Hom.: 273 AF XY: 0.0394 AC XY: 5349AN XY: 135630
GnomAD4 exome AF: 0.0480 AC: 70150AN: 1461424Hom.: 2035 Cov.: 30 AF XY: 0.0473 AC XY: 34384AN XY: 727034
GnomAD4 genome AF: 0.0368 AC: 5602AN: 152196Hom.: 156 Cov.: 32 AF XY: 0.0364 AC XY: 2711AN XY: 74410
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Feb 23, 2016 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 12, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Mitochondrial complex III deficiency nuclear type 5 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at